Cervical Cancer Clinical Trial
Official title:
Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania
The purpose of this study is to determine whether motivational text messages and/or travel vouchers are effective in increasing cervical cancer screening rates in urban and rural regions of Northern Tanzania.
Introduction:
Cervical cancer is the leading cause of cancer-related deaths in Tanzania. The age-adjusted
incidence rate is estimated to be 54 cases per 100,000 (IARC, 2012) and 80% of Tanzanian
women affected by cervical cancer will die due to advanced stage at diagnosis (Kahesa, et
al., 2012). Visual Inspection of the cervix under Acetic Acid (VIA) is an effective
alternative to the Pap smear, unavailable in most low-resource countries due to weak health
systems (Palanuwong, 2007). Nurses typically receive 6 days of training before returning to
their communities to provide VIA; however, they often face a total lack of oversight to
ensure they are providing quality screening and cryotherapy. This lack of quality control has
prevented a decline in cervical cancer morbidity and mortality despite significant investment
and implementation of VIA programs.
The Kilimanjaro Cervical Cancer Screening Project (KCCP) is a pilot study of 1000 women that
developed and tested a cervicography (taking a digital photo of the cervix) training method
using a smartphone camera in the hands of nurses performing cervical cancer screening and
receiving 'real time' mentorship through a closed user group of image transfer and guidance
by cervicographers located elsewhere in Tanzania. A pilot study completed in February 2015
showed that this method provides safe and high quality screening and the method is moving to
implementation and scale up within multiple VIA programs in late 2015 (Yeates et al.,
Manuscript in preparation). The KCCP continues to screen patients and this provides a
significant opportunity to perform further research that will inform the scale-up program.
Measures to encourage increased uptake of cervical cancer screening in the region, and in
many low-resource contexts are drastically needed to reduce the burden of cervical cancer in
these contexts. The prevalence of screening in the Kilimanjaro is 6%(Cunningham et al, 2015),
which is close to the WHO figure of 5% of women in developing countries having been screened
in the last five years (World Health Organization, 1986). The largest perceived barriers to
cervical cancer screening in the Kilimanjaro region were found to be a lack of knowledge that
screening services were available and women anticipated that they would not be able to afford
the costs associated with screening, including travel (Cunningham et al, 2015).
Objectives:
A) To determine attitudes, barriers and enablers towards smartphone cervicography to ensure
an accessible, culturally relevant smartphone cervicography screening program
B) To evaluate the impact of a voucher for return transportation towards increasing cervical
cancer screening attendance
C) To evaluate the impact of motivational text messages towards increasing cervical cancer
screening attendance
Methodology:
This study will comprise of a descriptive cross-sectional survey and a randomized controlled
trial (RCT). Household surveys, capturing baseline characteristics, using stratified
systematic random sampling in urban and rural areas will be used to recruit participants for
the RCT. Cross-sectional survey participants will be recruited opportunistically at screening
clinics associated with the study.
RCT participants will be randomized into one of three arms. The first arm will be a control
group and will not receive any correspondence. The second arm will receive a series of
motivational text messages, including screening dates and locations. The third group will
receive a travel voucher code via SMS and motivational text messages with the same content as
the second group.
A post-screening survey will be conducted following cervical cancer screening at clinics
participating in the study to evaluate screening attendance and attitudes towards smartphone
digital cervicography.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |